Literature DB >> 18629446

Acute in-vivo evaluation of bleeding with Gelfoam plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine.

George L Adams1, Roberto J Manson, Vic Hasselblad, Linda K Shaw, Jeffrey H Lawson.   

Abstract

BACKGROUND: Management of post-operative bleeding has historically used topical bovine thrombin. However, possible harm through activation of coagulation inhibitors has encouraged investigation with other hemostatic agents. This study utilized a novel ordinal bleeding model to test whether a Gelfoam + human thrombin solution is superior at controlling bleeding when compared to Gelfoam + saline solution at different time intervals. STUDY
DESIGN: Four swine underwent open laparotomy after receiving unfractionated heparin. Twenty open liver biopsies were performed in each swine; ten biopsies treated with Gelfoam + human thrombin solution and 10 biopsies treated with Gelfoam + saline solution. Three, 6 min, and 12 min after the procedure, bleeding was objectively graded by a four-point model.
RESULTS: There was a significant (P < 0.017), treatment effect on each success/failure outcome (success = bleeding score <or= 1; failure = bleeding score > 1) at 3 (P < 0.001), 6 (P < 0.001), and 12 (P = 0.003) min, based on a 2 x 2 Fisher's exact test. Similarly, there was a significant treatment effect on each success/failure outcome and four-point bleeding score based on a multiple logistic regression analysis controlling for pig, lesion weight, and initial bleeding taking into consideration repeated measures at three time points.
CONCLUSIONS: The results demonstrate a superior treatment effect for control of bleeding using human thrombin compared to a saline solution. Future studies should compare bovine thrombin versus human thrombins ability to control bleeding as well as the hazard of each in activating coagulation inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629446     DOI: 10.1007/s11239-008-0249-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  12 in total

1.  A technique of haemostasis of the extremities after debridement of burn wounds.

Authors:  Y Sawada; T Yotsuyanagi
Journal:  Burns       Date:  1992-10       Impact factor: 2.744

2.  Effect of thrombin-induced hemostasis on the efficacy of an absorbable adhesion barrier.

Authors:  D M Wiseman; L E Gottlick; M P Diamond
Journal:  J Reprod Med       Date:  1992-09       Impact factor: 0.142

3.  The role of topical thrombin in skin grafting.

Authors:  F A Ofodile; M K Sadana
Journal:  J Natl Med Assoc       Date:  1991-05       Impact factor: 1.798

4.  Evaluation of a novel hemostatic device in an ovine parenchymal organ bleeding model of normal and impaired hemostasis.

Authors:  A Simon Turner; Denise Parker; Barbara Egbert; Marcee Maroney; Rosa Armstrong; Noël Powers
Journal:  J Biomed Mater Res       Date:  2002

5.  Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

Authors:  T L Ortel; M C Mercer; E H Thames; K D Moore; J H Lawson
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

Review 6.  A review of the therapeutic uses of thrombin.

Authors:  Roger L Lundblad; Ralph A Bradshaw; Don Gabriel; Thomas L Ortel; Jeffrey Lawson; Kenneth G Mann
Journal:  Thromb Haemost       Date:  2004-05       Impact factor: 5.249

Review 7.  Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis.

Authors:  T L Ortel; L A Charles; F G Keller; P K Marcom; H N Oldham; W H Kane; B G Macik
Journal:  Am J Hematol       Date:  1994-02       Impact factor: 10.047

8.  Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves.

Authors:  R B Stricker; P K Lane; J D Leffert; G M Rodgers; M A Shuman; L Corash
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

9.  Femoral pseudoaneurysms: management with percutaneous thrombin injections--success rates and effects on systemic coagulation.

Authors:  Karsten Krüger; Markus Zähringer; Franz-Dietmar Söhngen; Axel Gossmann; Oliver Schulte; Christoph Feldmann; David Strohe; Klaus Lackner
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  The effectiveness of a fibrinogen-thrombin-collagen-based hemostatic agent in an experimental arterial bleeding model.

Authors:  G Schelling; T Block; E Blanke; C Hammer; W Brendel; M Gokel
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

View more
  13 in total

Review 1.  Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents.

Authors:  Devin T Miller; Dana M Roque; Alessandro D Santin
Journal:  Am J Obstet Gynecol       Date:  2015-01-08       Impact factor: 8.661

2.  Hemostatic Agents in Hepatobiliary and Pancreas Surgery: A Review of the Literature and Critical Evaluation of a Novel Carrier-Bound Fibrin Sealant (TachoSil).

Authors:  K A Simo; E M Hanna; D K Imagawa; D A Iannitti
Journal:  ISRN Surg       Date:  2012-09-13

3.  Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents.

Authors:  K M Lewis; D Spazierer; M D Urban; L Lin; H Redl; A Goppelt
Journal:  Eur Surg       Date:  2013-07-04       Impact factor: 0.953

4.  Next Generation Hemostatic Materials Based on NHS-Ester Functionalized Poly(2-oxazoline)s.

Authors:  Marcel A Boerman; Edwin Roozen; María José Sánchez-Fernández; Abraham R Keereweer; Rosa P Félix Lanao; Johan C M E Bender; Richard Hoogenboom; Sander C Leeuwenburgh; John A Jansen; Harry Van Goor; Jan C M Van Hest
Journal:  Biomacromolecules       Date:  2017-07-25       Impact factor: 6.988

5.  SPOT GRADE II: Clinical Validation of a New Method for Reproducibly Quantifying Surgical Wound Bleeding: Prospective, Multicenter, Multispecialty, Single-Arm Study.

Authors:  Daniel J Del Gaizo; William D Spotnitz; Rachel W Hoffman; Mark Christopher Hermann; Linda S Sher; Russell H Spotnitz; Yuri S Genyk; Ian J Schorn; Daniel L Gillen; Bobby L White; Bruce G Miller; Roberto J Manson
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  Topical recombinant thrombin at a concentration of 1000 IU/mL reliably shortens in vivo TTH and delivers durable hemostasis in the presence of heparin anticoagulation and clopidogrel platelet inhibition in a rabbit model of vascular bleeding.

Authors:  Steven D Hughes; Paul D Bishop; Richard Garcia; Tracy Zhang; W Allan Alexander
Journal:  Ann Surg Innov Res       Date:  2009-11-19

7.  Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.

Authors:  Kevin M Lewis; Holly D Atlee; Angela J Mannone; Joseph Dwyer; Lawrence Lin; Andreas Goppelt; Heinz Redl
Journal:  J Invest Surg       Date:  2013-03-20       Impact factor: 2.533

8.  Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models.

Authors:  Kevin M Lewis; Jeff McKee; Alexandra Schiviz; Alexander Bauer; Martin Wolfsegger; Andreas Goppelt
Journal:  ISRN Surg       Date:  2014-03-04

9.  Improved bleeding scores using Gelfoam(®) Powder with incremental concentrations of bovine thrombin in a swine liver lesion model.

Authors:  Dennis C Morse; Elif Silva; Jolee Bartrom; Kelli Young; Eric J Bass; David Potter; Trevor Bieber
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

10.  Comparison of the efficacy of five standard topical hemostats: a study in porcine liver and spleen models of surgical bleeding.

Authors:  Valerio Antonio Paternò; Alessandro Bisin; Alessandro Addis
Journal:  BMC Surg       Date:  2020-09-25       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.